Financial statements Axen Bio Group
Balance sheet of Axen Bio Group
Company age:
Age:
10 y. 4 m. 25 d.
Share capital:
Share capital:
10 000 PLN
Balance sheet data of AXEN BIO GROUP
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 294 408,00 | 1 328 803,51 | 1 208 624,31 | 1 292 101,26 | 1 090 016,90 | 943 238,79 |
| A. Fixed assets | 1 170 225,49 | 1 101 312,82 | 977 318,11 | 875 980,48 | 780 000,00 | 693 333,33 |
| B. Current assets | 124 182,51 | 227 490,69 | 231 306,20 | 416 120,78 | 310 016,90 | 249 905,46 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 294 408,00 | 1 328 803,51 | 1 208 624,31 | 1 292 101,26 | 1 090 016,90 | 943 238,79 |
| A. Equity | 1 216 162,50 | 1 003 667,26 | 891 271,28 | 925 031,64 | 654 741,96 | 378 335,23 |
| B. Liabilities and provisions for liabilities | 78 245,50 | 325 136,25 | 317 353,03 | 367 069,62 | 435 274,94 | 564 903,56 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 78 245,50 | 325 136,25 | 317 353,03 | 367 069,62 | 435 274,94 | 564 903,56 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.